ClassID:

20077

A61K9/146 - page 4 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Recent Application in this class:
#901
20160095933
2016-04-07

Water soluble polycarbonates for medical applications

#902
20160095928
2016-04-07

Composition for hot melt extrusion and method for producing hot melt extrudate by using same

#903
20160090415
2016-03-31

METHODS TO PRODUCE PARTICLES COMPRISING THERAPEUTIC PROTEINS

#904
20160089389
2016-03-31

Chemoembolisation

#905
20160089369
2016-03-31

Aqueous suspensions of TMC278

#906
20160089353
2016-03-31

Oral pharmaceutical composition of isotretinoin

#907
20160082125
2016-03-24

Salipro particles

#908
20160081932
2016-03-24

NEUTRALLY-CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT RESPONSE

#909
20160075700
2016-03-17

Yellow reduced pyrroloquinoline quinone crystal and method of producing the same, and food, pharmaceutical, gel, composition and method of producing composition

#910
20160074433
2016-03-17

TREATING AGENT AND TREATING METHOD FOR THE EXAMINATION OR OPERATION OF THE LARGE INTESTINE

#911
20160074383
2016-03-17

Orally administrable compositions and methods of deterring abuse by intranasal administration

#912
20160074327
2016-03-17

PROCESS FOR PREPARING MICROPARTICLES

#913
20160067206
2016-03-10

Composition for preventing or treating renal fibrosis comprising dimethylfumarate as active ingredient

#914
20160060264
2016-03-03

Urea derivatives and uses thereof

#915
20160058868
2016-03-03

Solid dosage form containing arabinogalactan

#916
20160051522
2016-02-25

THERAPEUTIC POLYMERIC NANOPARTICLES COMPRISING EPOTHILONE AND METHODS OF MAKING AND USING SAME

#917
20160051471
2016-02-25

Mesoporous silica-coated nanoparticles

#918
20160045585
2016-02-18

Formulations

#919
20160045553
2016-02-18

CELL DELIVERY

#920
20160038569
2016-02-11

Particles containing a growth factor, and uses thereof

#921
20160030574
2016-02-04

PHARMACEUTICAL COMPOSITION 271

#922
20160022764
2016-01-28

Pharmaceutical compositions

#923
20160022637
2016-01-28

Formulation of indomethacin

#924
20160022581
2016-01-28

Processes for making cyclic lipid implants for intraocular use

#925
20160015718
2016-01-21

Oil-in-water method for making polymeric implants containing a hypotensive lipid

#926
20160015639
2016-01-21

Cyclodextrin compositions encapsulating a selective ATP inhibitor and uses thereof

#927
20160015638
2016-01-21

STABLE GLUCOKINASE ACTIVATOR COMPOSITIONS

#928
20160008399
2016-01-14

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

#929
20160008284
2016-01-14

Pain relieving compositions comprising elemental metals

#930
20150376299
2015-12-31

Esterified cellulose ethers of very low viscosity

#931
20150374827
2015-12-31

Solid dispersions of low-water solubility actives

#932
20150374627
2015-12-31

NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS

#933
20150374394
2015-12-31

SONOLYSIS WITH BIODEGRADABLE NANOPARTICLES

#934
20150368366
2015-12-24

Esterified cellulose ethers of very high molecular weight

#935
20150366859
2015-12-24

Solid dispersion comprising amorphous cilostazol

#936
20150366806
2015-12-24

Method of Engineering Nanoparticle

#937
20150359735
2015-12-17

Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same

#938
20150352049
2015-12-10

Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract

#939
20150342885
2015-12-03

Ultra low density pulmonary powders

#940
20150342884
2015-12-03

Solid dosage form comprising micronized cytisine and its production method

#941
20150335653
2015-11-26

PHARMACEUTICAL COMPOSITIONS OF LINEZOLID

#942
20150328215
2015-11-19

STABLE AMORPHOUS RALTEGRAVIR POTASSIUM PREMIX AND PROCESS FOR THE PREPARATION THEREOF

#943
20150328158
2015-11-19

Hydrophilic matrix beadlet compositions with enhanced bioavailability

#944
20150320736
2015-11-12

Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

#945
20150320714
2015-11-12

Powderous formulation

#946
20150320682
2015-11-12

NANOPARTICULATE MEGESTROL FORMULATIONS

#947
20150314000
2015-11-05

Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

#948
20150313844
2015-11-05

Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose

#949
20150313843
2015-11-05

Solid ganaxolone compositions and methods for the making and use thereof

#950
20150306247
2015-10-29

Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient

#951
20150290199
2015-10-15

Linagliptin solid dispersion

#952
20150284507
2015-10-08

Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof

#953
20150283249
2015-10-08

Amorphous form of apremilast

#954
20150283243
2015-10-08

Solid dispersions of insoluble drug and preparation method thereof

#955
20150283089
2015-10-08

Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities

#956
20150265575
2015-09-24

Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)

#957
20150258219
2015-09-17

ELECTROSTATIC-BONDING-TYPE VESICLE INCLUDING METAL MICROPARTICLES

#958
20150258118
2015-09-17

CO-MICRONISATION PRODUCT COMPRISING A SELECTIVE PROGESTERONE-RECEPTOR MODULATOR

#959
20150258066
2015-09-17

Method for producing fine powder and the fine powder produced by the same

#960
20150250744
2015-09-10

Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles

#961
20150250727
2015-09-10

Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast

#962
20150238534
2015-08-27

NOVEL HOLLOW PARTICLES

#963
20150238419
2015-08-27

Partially absorbable fiber-reinforced composites for controlled drug delivery

#964
20150238416
2015-08-27

Pharmaceutical composition

#965
20150224087
2015-08-13

Amorphous mirabegron and processes for crystal forms of mirabegron

#966
20150216942
2015-08-06

Nanoparticle-insulin and insulin analogue compositions

#967
20150209436
2015-07-30

COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A CELLULOSE ETHER OF VERY LOW VISCOSITY

#968
20150209284
2015-07-30

DUAL-TARGETING DRUG CARRIER AND METHOD FOR FABRICATING THE SAME

#969
20150203597
2015-07-23

Partially cross-linked esterified cellulose ethers

#970
20150196532
2015-07-16

Glycopyrrolate salts

#971
20150196489
2015-07-16

POLYMER MATRICES FOR CONTROLLING CRYSTALLIZATION

#972
20150190518
2015-07-09

Pharmaceutical compositions providing enhanced drug concentrations

#973
20150190417
2015-07-09

Method of making an anhydrous, fat soluble, chewable drug delivery formulation

#974
20150190374
2015-07-09

Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide

#975
20150182470
2015-07-02

RECONSTITUTED APOLIPOPROTEIN B LIPOPARTICLE, A PREPARATION METHOD AND USES THEREOF

#976
20150182461
2015-07-02

Mass Production and Size Control of Nanoparticles Through Controlled Microvortices

#977
20150174071
2015-06-25

Dissolution enhanced controlled drug delivery system for poorly water soluble drugs

#978
20150174065
2015-06-25

Solid pharmaceutical composition of cation exchange resin

#979
20150166696
2015-06-18

Polymer particles

#980
20150157639
2015-06-11

Solid dispersions containing an apoptosis-inducing agent

#981
20150157573
2015-06-11

Formulation of diclofenac

#982
20150151029
2015-06-04

Implantable polymeric device for sustained release of dopamine agonist

#983
20150151008
2015-06-04

Contrast Media Taste Masking Formulations

#984
20150150824
2015-06-04

Formulation of diclofenac

#985
20150150804
2015-06-04

Cellulose powder

#986
20150148295
2015-05-28

Controlled-Released Peptide Formulations

#987
20150147396
2015-05-28

Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof

#988
20150141457
2015-05-21

ELVITEGRAVIR SOLID DISPERSION

#989
20150140113
2015-05-21

Gelling agent-based dosage form

#990
20150140109
2015-05-21

DOCETAXEL-BASED PROLONGED-RELEASE CANCER TREATMENT DRUG

#991
20150140091
2015-05-21

Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose

#992
20150140042
2015-05-21

Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections

#993
20150133482
2015-05-14

Formulations of rifaximin and uses thereof

#994
20150133464
2015-05-14

Injectable particle

#995
20150125535
2015-05-07

Crystalline forms of therapeutic compounds and uses thereof

#996
20150119432
2015-04-30

Isoxazoline compound composition

#997
20150110878
2015-04-23

Nanoparticles of indirubin, derivatives thereof and methods of making and using same

#998
20150110837
2015-04-23

Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same

#999
20150104508
2015-04-16

DEVICES, COMPOSITIONS, AND METHODS FOR FABRICATING DRUG DELIVERY SYSTEMS

#1000
20150087625
2015-03-26

Pharmaceutical composition and use

#1001
20150086635
2015-03-26

Nanoparticulate megestrol formulations

#1002
20150073146
2015-03-12

Preparation of ticagrelor

#1003
20150072986
2015-03-12

Urea derivatives and uses thereof

#1004
20150072011
2015-03-12

Carboxylvinyl polymer-containing nanoparticle suspensions

#1005
20150065547
2015-03-05

Esterified cellulose ethers having a specific substituent distribution

#1006
20150056287
2015-02-26

Nanoparticulate megestrol formulations

#1007
20150056286
2015-02-26

Nanoparticulate megestrol formulations

#1008
20150050357
2015-02-19

Nanoparticle isoflavone compositions and methods of making and using the same

#1009
20150050335
2015-02-19

Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same

#1010
20150045748
2015-02-12

Transdermal device including porous microparticles

#1011
20150045455
2015-02-12

Co-precipitation method

#1012
20150044289
2015-02-12

Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate

#1013
20150038491
2015-02-05

Solid ivabradine-containing composition

#1014
20150031707
2015-01-29

Method for preparing nano particles

#1015
20150030686
2015-01-29

Self-assembled toroidal-spiral particles and manufacture and uses thereof

#1016
20150028503
2015-01-29

Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus

#1017
20150025024
2015-01-22

Solid compositions

#1018
20150024047
2015-01-22

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

#1019
20150018420
2015-01-15

Method of controlling the release of an active ingredient from a dosage form

#1020
20150018390
2015-01-15

Methods and compositions for treating post-operative pain comprising a local anesthetic

#1021
20150018324
2015-01-15

Testosterone undecanoate compositions

#1022
20150017250
2015-01-15

Tamper-resistant dosage form containing ethylene-vinyl acetate polymer

#1023
20150011504
2015-01-08

Hydrogel compositions

#1024
20150010642
2015-01-08

Composition of a bone repair mixture

#1025
20150004243
2015-01-01

Microparticles manufactured in an oil-in-water process comprising a prostamide

#1026
20150004234
2015-01-01

Nanoparticulate compositions and formulations of piperazine compounds

#1027
20140378490
2014-12-25

Formulations of phenyl uracil compounds

#1028
20140371166
2014-12-18

Antibiotic composition for inhalation and irrigation

#1029
20140371139
2014-12-18

Preparations containing amorphous emodepside

#1030
20140357681
2014-12-04

Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same

#1031
20140356444
2014-12-04

Drug loaded polymeric nanoparticles and methods of making and using same

#1032
20140356426
2014-12-04

Tamper-resistant dosage form containing one or more particles

#1033
20140348914
2014-11-27

Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

#1034
20140342003
2014-11-20

Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery

#1035
20140341998
2014-11-20

Pharmaceutical composition for inhalation

#1036
20140335193
2014-11-13

CONTROLLED-RELEASE INJECTABLE MICROPARTICLE

#1037
20140329913
2014-11-06

NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION

#1038
20140328917
2014-11-06

Organic compound nano-powder, method for producing the same and suspension

#1039
20140328763
2014-11-06

Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity

#1040
20140322325
2014-10-30

Pharmaceutical compositions providing enhanced drug concentrations

#1041
20140322189
2014-10-30

Composition based on ubidecarenone

#1042
20140296336
2014-10-02

Solid retard formulations based on solid dispersions

#1043
20140294982
2014-10-02

Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions

#1044
20140294980
2014-10-02

Sustained release particle formulations

#1045
20140294752
2014-10-02

Method for nucleic acid delivery using hyaluronic acid

#1046
20140287043
2014-09-25

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

#1047
20140287038
2014-09-25

Orally effective methylphenidate extended release powder and aqueous suspension product

#1048
20140286872
2014-09-25

Nanoparticle for targeting brain tumors and delivery of O-benzylguanine

#1049
20140275037
2014-09-18

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

#1050
20140271898
2014-09-18

Abuse deterrent compositions and methods of use

#1051
20140271895
2014-09-18

Polymorph compositions, methods of making, and uses thereof

#1052
20140271894
2014-09-18

MATRIX-INCORPORATED FLUORESCENT POROUS SILICA PARTICLES FOR DRUG DELIVERY

#1053
20140271884
2014-09-18

HIGH-LOADING NANOPARTICLE-BASED FORMULATION FOR WATER-INSOLUBLE STEROIDS

#1054
20140271780
2014-09-18

Prostamide-containing intraocular implant

#1055
20140256781
2014-09-11

Formulation of indomethacin

#1056
20140255494
2014-09-11

Formulation of indomethacin

#1057
20140255480
2014-09-11

PHARMACEUTICAL FORMULATION OF NANONIZED FENOFIBRATE

#1058
20140248365
2014-09-04

NANOPARTICLE PEPTIDE COMPOSITIONS

#1059
20140248359
2014-09-04

Formulation of diclofenac

#1060
20140242162
2014-08-28

PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN

#1061
20140235706
2014-08-21

Cancer cell targeting using nanoparticles

#1062
20140234392
2014-08-21

Physically and chemically stable nicotine-containing particulate material

#1063
20140234225
2014-08-21

METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER

#1064
20140224680
2014-08-14

KIT-OF-PARTS

#1065
20140220126
2014-08-07

Abuse-deterrent pharmaceutical compositions for controlled release

#1066
20140220121
2014-08-07

Formulation of diclofenac

#1067
20140213542
2014-07-31

Composition containing S-adenosyl-L-methionine with excellent storage stability

#1068
20140212503
2014-07-31

DELIVERY SYSTEM

#1069
20140212466
2014-07-31

Method of preparing carrier liquids

#1070
20140210117
2014-07-31

Pharmaceutical compositions of dispersions of drug and neutral polymers

#1071
20140206759
2014-07-24

PROCESS FOR THE PRODUCTION OF BIODEGRADEABLE, FUNCTIONALISED POLYMER PARTICLES, AND USE THEREOF AS PHARMACEUTICAL SUPPORTS

#1072
20140206742
2014-07-24

Pharmaceutical composition with improved bioavailability

#1073
20140200267
2014-07-17

Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof

#1074
20140194487
2014-07-10

Formulation of indomethacin

#1075
20140193513
2014-07-10

Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof

#1076
20140193505
2014-07-10

BIODEGRADABLE CARRIER WITH ADJUSTABLE ZETA POTENTIALS AND PARTICLE SIZES, METHOD FOR MAKING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#1077
20140186446
2014-07-03

Delivery of biologic therapeutics

#1078
20140186445
2014-07-03

METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF

#1079
20140179803
2014-06-26

Continuous flow production of gelatin nanoparticles

#1080
20140170224
2014-06-19

GELATIN-BASED MICROGELS

#1081
20140163071
2014-06-12

Bioavailable compositions of amorphous piperidinyl compounds

#1082
20140161893
2014-06-12

POLYMER BLEND PARTICLES FOR INTRACELLULAR DELIVERY OF AGENTS

#1083
20140161853
2014-06-12

Non-irritating benzoyl peroxide

#1084
20140155627
2014-06-05

Process for forming amorphous atorvastatin

#1085
20140154309
2014-06-05

Solid ganaxolone compositions and methods for the making and use thereof

#1086
20140148449
2014-05-29

Highly loaded amorphous efavirenz composition and process for preparing the same

#1087
20140141084
2014-05-22

Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases

#1088
20140134244
2014-05-15

Antifungal compositions with improved bioavailability

#1089
20140128416
2014-05-08

MEDICAL DEVICES INCORPORATING COLLAGEN INHIBITORS

#1090
20140127311
2014-05-08

BIO-COMPATIBLE NANO-POLYMER PARTICLES COMPRISING ACTIVE INGREDIENTS FOR PULMONARY APPLICATION

#1091
20140120168
2014-05-01

METASTABLE SILVER NANOPARTICLE COMPOSITES

#1092
20140112996
2014-04-24

Compositions comprising methylphenidate complexed with ion-exchange resin particles

#1093
20140105984
2014-04-17

Reduction of flake-like aggregation in nanoparticulate active agent compositions

#1094
20140099371
2014-04-10

Medicinal carriers, and preparation method and uses thereof

#1095
20140079795
2014-03-20

Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance

#1096
20140079756
2014-03-20

Compressed chewing gum tablet

#1097
20140079644
2014-03-20

CELLULOSE-BASED NANOPARTICLES FOR DRUG DELIVERY

#1098
20140079642
2014-03-20

NANOPARTICLES BASED FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS

#1099
20140072646
2014-03-13

Thyroid hormone analogs and methods of use

#1100
20140072643
2014-03-13

Methods of treating cancer

#1101
20140072604
2014-03-13

Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient

#1102
20140065211
2014-03-06

Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

#1103
20140056982
2014-02-27

Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids

#1104
20140056981
2014-02-27

METHOD FOR PRODUCING DRUG-LOADED POLYMERIC NANOPARTICLES BY POLYMERIZATION IN PRESENCE OF DRUGS

#1105
20140044787
2014-02-13

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS

#1106
20140044780
2014-02-13

Extended-Release Levetiracetam and Method of Preparation

#1107
20140039070
2014-02-06

Compositions and methods of delivery of pharmacological agents

#1108
20140039069
2014-02-06

Compositions and methods of delivery of pharmacological agents

#1109
20140038998
2014-02-06

STABILIZED TACROLIMUS COMPOSITION

#1110
20140038931
2014-02-06

Method for producing a composite organic compound powder for medical use

#1111
20140037728
2014-02-06

Compositions comprising methylphenidate complexed with ion-exchange resin particles

#1112
20140030352
2014-01-30

NANODISPERSION

#1113
20140030351
2014-01-30

Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers

#1114
20140030350
2014-01-30

Drug Delivery Systems

#1115
20140030336
2014-01-30

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DISORDERS

#1116
20140023688
2014-01-23

ENCAPSULATED OILS

#1117
20140017330
2014-01-16

Activated Nucleoside Analog Conjugates and Methods of Use Thereof

#1118
20140017319
2014-01-16

Process for producing cellulose derivatives of high bulk density and good flowability

#1119
20140017315
2014-01-16

METHODS AND COMPOSITIONS FOR TREEATING PROLIFERATIVE DISEASES

#1120
20140017314
2014-01-16

Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus

#1121
20140017313
2014-01-16

Formulations

#1122
20140010879
2014-01-09

Compositions and methods of treating therapy resistant cancer and uses thereof

#1123
20140010873
2014-01-09

Abuse deterrent pharmaceutical compositions for controlled release

#1124
20140005204
2014-01-02

Itraconazole compositions with improved bioavailability

#1125
20140004196
2014-01-02

POLYAMIDE-AMINE DENDRIMER OR DERIVATIVE THEREOF-MATH1 GENE NANO PARTICLE AND USE THEREOF IN TREATMENT OF HEARING LOSS

#1126
20140004160
2014-01-02

Orally effective methylphenidate extended release powder and aqueous suspension product

#1127
20130345320
2013-12-26

Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers

#1128
20130344116
2013-12-26

Oral particle consisting of an amorphous structure and a submicron domain

#1129
20130337070
2013-12-19

Coated Nanoparticle Therapy for Skin Cancer

#1130
20130337067
2013-12-19

NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM

#1131
20130323311
2013-12-05

Collagen-targeted nanoparticles

#1132
20130323306
2013-12-05

INJECTABLE BIODEGRADABLE PARTICLES FOR CONTROLLED THERAPEUTIC AGENT RELEASE

#1133
20130323183
2013-12-05

Absorbent dressings with painkilling activity

#1134
20130316010
2013-11-28

POLYMERIC MICROPARTICLES

#1135
20130316008
2013-11-28

MULTICOMPARTMENTALIZED VESICULAR STRUCTURE AND A METHOD FOR FORMING THE SAME

#1136
20130303630
2013-11-14

Thermo-kinetic mixing for pharmaceutical applications

#1137
20130302431
2013-11-14

Polymorph compositions, methods of making, and uses thereof

#1138
20130295190
2013-11-07

Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents

#1139
20130295189
2013-11-07

Method for manufacturing acid pellets

#1140
20130287851
2013-10-31

Liquid ganaxolone formulations and methods for the making and use thereof

#1141
20130287847
2013-10-31

Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binder

#1142
20130287832
2013-10-31

Soluble needle arrays for delivery of influenza vaccines

#1143
20130280339
2013-10-24

Drug loaded polymeric nanoparticles and methods of making and using same

#1144
20130274192
2013-10-17

MICROPARTICLES CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#1145
20130273163
2013-10-17

Drug-delivery systems

#1146
20130273117
2013-10-17

Methods and systems for generating nanoparticles

#1147
20130251817
2013-09-26

Cancer cell targeting using nanoparticles

#1148
20130251816
2013-09-26

Cancer cell targeting using nanoparticles

#1149
20130251779
2013-09-26

Product

#1150
20130244952
2013-09-19

Compositions and methods of delivery of pharmacological agents

#1151
20130243869
2013-09-19

Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles

#1152
20130243864
2013-09-19

Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage

#1153
20130243832
2013-09-19

Poly(vinyl benzoate) nanoparticles for molecular delivery

#1154
20130236554
2013-09-12

Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles

#1155
20130236550
2013-09-12

PHARMACEUTICAL MICROPARTICLES

#1156
20130236500
2013-09-12

Drug loaded polymeric nanoparticles and methods of making and using same

#1157
20130230567
2013-09-05

Drug loaded polymeric nanoparticles and methods of making and using same

#1158
20130216592
2013-08-22

PARTICLES CONSISTING OF A CHITOSAN POLYELECTROLYTE COMPLEX AND OF AN ANIONIC POLYSACCHARIDE, AND HAVING IMPROVED STABILITY

#1159
20130209518
2013-08-15

Combinations and modes of administration of therapeutic agents and combination therapy

#1160
20130195953
2013-08-01

Methods and formulations for administration of resolvin anti-inflammatory compounds

#1161
20130195933
2013-08-01

Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer

#1162
20130190229
2013-07-25

Vitamin E formulations of sulfamide NS3 inhibitors

#1163
20130172426
2013-07-04

Fat-reducing agent

#1164
20130172392
2013-07-04

Solid dispersion preparation

#1165
20130164381
2013-06-27

Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation

#1166
20130164345
2013-06-27

Co-processing method and formulations for HIV attachment inhibitor prodrug compound and excipients

#1167
20130160782
2013-06-27

Snuff composition

#1168
20130157992
2013-06-20

Sustained drug release and improved product stability using non-covalent particle coating methods

#1169
20130150397
2013-06-13

Rapamycin composition

#1170
20130137976
2013-05-30

Functional, cross-linked nanostructures for tandem optical imaging and therapy

#1171
20130136688
2013-05-30

Nanoparticles for Targeted Delivery of Active Agents to the Lung

#1172
20130129828
2013-05-23

Compositions and methods for delivery of poorly soluble drugs

#1173
20130129817
2013-05-23

Method of treating malignant solid tumors

#1174
20130129810
2013-05-23

Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

#1175
20130123353
2013-05-16

Dronedarone solid dispersion and preparation method thereof

#1176
20130122058
2013-05-16

Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation

#1177
20130121918
2013-05-16

Nano-hybrid delivery system for sequential utilization of passive and active targeting

#1178
20130115165
2013-05-09

Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles

#1179
20130108668
2013-05-02

Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same

#1180
20130102691
2013-04-25

Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution

#1181
20130102588
2013-04-25

Tolvaptan solid dispersion and its preparation method

#1182
20130101632
2013-04-25

NANOPARTICULATE FORMULATIONS OF MITHRAMYCIN OR MITHRAMYCIN ANALOGUES FOR TREATING CANCER

#1183
20130072531
2013-03-21

SOLID DISPERSION COMPRISING AN ANTI-HIV AGENT

#1184
20130071484
2013-03-21

Self-assembled toroidal-spiral particles and manufacture and uses thereof

#1185
20130071475
2013-03-21

Method for producing an immediately decomposing oral form of administration which releases active ingredients

#1186
20130064896
2013-03-14

Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer

#1187
20130059795
2013-03-07

Composition of matter for delivering lipid-soluble materials, and a method for producing it

#1188
20130045251
2013-02-21

Pharmaceutical composition for improving dissolution rate of prasugrel and its preparation method

#1189
20130039952
2013-02-14

CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS

#1190
20130035355
2013-02-07

Prasugrel in micronized, crystalline form and pharmaceutical composition thereof

#1191
20130035345
2013-02-07

Solid dispersion formulations and methods of use thereof

#1192
20130034603
2013-02-07

Process for preparing pharmaceutical compositions of fingolimod

#1193
20130029965
2013-01-31

Pharmaceutical solid dispersions

#1194
20130028938
2013-01-31

Solid pharmaceutical dosage form of ticagrelor

#1195
20130028932
2013-01-31

Compositions comprising polyglutamic acid nanoparticles and CD40 agonists

#1196
20130022672
2013-01-24

Stabilized Amorphous Forms of Imatinib Mesylate

#1197
20130018101
2013-01-17

SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF

#1198
20130017254
2013-01-17

PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE

#1199
20130011447
2013-01-10

CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS

#1200
20130005823
2013-01-03

METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS